Peer Review reports
From: Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
Original Submission | ||
---|---|---|
23 Aug 2017 | Submitted | Original manuscript |
7 Nov 2017 | Author responded | Author comments - HUIGUO DING |
Resubmission - Version 2 | ||
7 Nov 2017 | Submitted | Manuscript version 2 |
8 Mar 2018 | Reviewed | Reviewer Report - Yoshihiko Yano |
10 May 2018 | Reviewed | Reviewer Report - Evangelos Cholongitas |
15 May 2018 | Reviewed | Reviewer Report - Nobuyuki Toshikuni |
13 Jun 2018 | Author responded | Author comments - HUIGUO DING |
Resubmission - Version 3 | ||
13 Jun 2018 | Submitted | Manuscript version 3 |
24 Jun 2018 | Reviewed | Reviewer Report - Nobuyuki Toshikuni |
7 Jul 2018 | Reviewed | Reviewer Report - Evangelos Cholongitas |
26 Jul 2018 | Author responded | Author comments - Shuzhen Wang |
Resubmission - Version 4 | ||
26 Jul 2018 | Submitted | Manuscript version 4 |
Publishing | ||
3 Aug 2018 | Editorially accepted | |
4 Sep 2018 | Article published | 10.1186/s12876-018-0857-0 |
You can find further information about peer review here.